🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate whether hypofractionated who...
Status
Recruiting
Location
Siriraj Hospital
Start Date
2026-08-03
Trial ID
NCT07709650
Treatments Being Tested
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This is a phase II, single arm, multi-centre study to assess the efficacy o...
Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Start Date
2022-02-22
Trial ID
NCT04575961
Treatments Being Tested
To explore the efficacy and safety of vebreltinib plus platinum-doublet che...
Status
Not Yet Recruiting
Location
241 West Huaihai Road, Xuhui District, Shanghai, 200030, China.
Start Date
2026-03-30
Trial ID
NCT07549061
Treatments Being Tested
The purpose of this prospective study is to perform Nerve conduction test, ...
Status
Unknown
Location
Himalayan Hospital(Cancer Research Institute), Himalayan Institute of Medical Sciences
Start Date
2022-11-23
Trial ID
NCT06491082
Treatments Being Tested
The purpose of this randomized study is to determine the safety and efficac...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2021-09-03
Trial ID
NCT04486833
Treatments Being Tested
The purpose of this study is to find out if SU011248 works and if it is saf...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2008-04
Trial ID
NCT00578526
The combination of pEBV DNA (half-life) and PET-CT following 1 course of ch...
Status
Completed
Location
Department of Clinical Oncology, Prince of Wales Hospital
Start Date
2011-07
Trial ID
NCT01365208
Treatments Being Tested
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958